利培酮引起的高泌乳素相关因素分析

doi:10.3969/j.issn.1673-8640.2022.02.005

摘要/Abstract

摘要：

目的探讨利培酮所致高泌乳素（PRL）的危险因素,以指导临床合理用药。方法选取使用利培酮治疗6周的精神分裂症患者90例,收集其临床一般资料,包括性别、年龄、体质量指数（BMI）及阳性和阴性症状量表（PANSS）评分,检测所有患者的利培酮血药浓度、空腹血糖、总胆固醇（TC）、三酰甘油（TG）和PRL水平。依据血浆PRL水平将患者分为高PRL（PRL≥30 ng/mL）组和正常PRL（PRL<30 ng/mL）组。结果高PRL组女性比例高于正常PRL组（P<0.001）,PANSS评分和空腹血糖低于正常PRL组（P<0.001）,2个组之间年龄、BMI、TC、TG、利培酮血药浓度差异均无统计学意义（P>0.05）。Logistic回归分析结果显示,性别（女性）、PANSS评分降低和空腹血糖降低是高PRL的危险因素[比值比（OR）值分别为15.843、0.466、0.053,95%可信区间（CI）分别为5.329~47.105、0.259~0.838、0.014~0.202,P<0.05]。年龄、BMI、TC、TG和利培酮血药浓度均不是高PRL的危险因素（OR值分别为1.016、1.623、0.449、0.650、0.399,P>0.05）。高PRL女性患者的PRL水平显著高于男性（P<0.001）。结论女性患者服用利培酮易发生高PRL,服用利培酮患者PANSS评分和空腹血糖过低易发生高PRL。建议临床个性化给药。

关键词: 泌乳素, 利培酮, 精神分裂症, 相关性

Abstract:

Objective To study high prolactin（PRL） caused by risperidone-related factors,and to guide clinicians using drugs rationally. Methods Totally,90 patients with schizophrenia were enrolled after treatment of risperidone for 6 weeks. The general data,including age,sex,body mass index（BMI）,positive and negative syndrome scale（PANSS） score,plasma concentration of risperidone,fasting blood glucose,total cholesterol（TC）,triglyceride（TG） and the level of PRL,were collected. According to plasma concentrations of PRL,the research subjects were classified into high PRL group（PRL≥30 ng/mL） and normal PRL group（PRL<30 ng/mL）. Results The proportion of females in high PRL group was higher than that in normal PRL group（P<0.001）,and PANSS score and fasting blood glucose were lower than those in normal PRL group（P<0.001）. Age,BMI,TC,TG and plasma concentration of risperidone had no statistical significance between the 2 groups（P>0.05）. Logistic regression analysis showed that high PRL was associated with sex（female）,PANSS score and fasting blood glucose [odds ratios（OR） were 15.843,0.466 and 0.053,95% confidence intervals（CI） were 5.329-47.105,0.259-0.838 and 0.014-0.202,P<0.05]. Age,BMI,TC,TG and plasma concentration of risperidone were not risk factors for high PRL（OR=1.016,1.623,0.449,0.650 and 0.399,P>0.05）. PRL in female patients was higher than that in male patients（P<0.001）. Conclusions Female patients taking risperidone are easier to be high PRL,and patients taking risperidone with low PANSS score and low fasting blood glucose are tended to be high PRL. Clinicians should use individualized medication.

Key words: Prolactin, Risperidone, Schizophrenia, Correlation

中图分类号:

R446.1

陈秋莹, 钟盈花, 赵楠, 殷海波, 徐阳, 舒铭. 利培酮引起的高泌乳素相关因素分析[J]. 检验医学, 2022, 37(2): 122-125.

CHEN Qiuying, ZHONG Yinghua, ZHAO Nan, YIN Haibo, XU Yang, SHU Ming. High prolactin caused by risperidone related factors[J]. Laboratory Medicine, 2022, 37(2): 122-125.

图/表 3

参考文献 15

[1]	DA FONSECA B M, MORENO I E, BARROSO M, et al. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry[J]. Anal Bioanal Chem, 2013, 405(12):3953-3963. DOI URL
[2]	SERRI O, CHIK C L, UR E, et al. Diagnosis and management of hyperprolactinemia[J]. CMAJ, 2003, 169(6):575-581.
[3]	中华医学会精神医学分会精神分裂症协作组. 精神分裂症患者代谢综合征管理的中国专家共识[J]. 中华精神科杂志, 2020, 53(1):3-10.
[4]	ALOSAIMI F D, FALLATA E O, ABALHASSAN M, et al. Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications[J]. Int J Psychiatry Clin Pract, 2018, 22(4):274-281. DOI URL
[5]	AURIEMMA R S, DE ALCUBIERRE D, PIRCHIO R, et al. Glucose abnormalities associated to prolactin secreting pituitary adenomas[J]. Front Endocrinol(Lausanne), 2019, 10:327.
[6]	RAMPINO A, MARAKHOVSKAIA A, SOARES-SILVA T, et al. Antipsychotic drug responsiveness and dopamine receptor signaling;old players and new prospects[J]. Front Psychiatry, 2019, 9:702.
[7]	ANDERSEN M, GLINTBORG D. Metabolic syndrome in hyperprolactinemia[J]. Front Horm Res, 2018, 49:29-47.
[8]	ZHANG C, MAO Y, SONG L. Precise treatments for schizophrenia:where is the way forward?[J]. Gen Psychiatr, 2018, 31(1):e000002.
[9]	JING Y, WANG X, YU J, et al. Associations of serum sex hormone binding globulin with bone mineral densities and higher 10-year probability of fractures in postmenopausal women with type 2 diabetes mellitus[J]. Ann Transl Med, 2019, 7(18):457. DOI URL
[10]	HE S, YU W J, WANG X, et al. Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids[J]. Gen Psychiatr, 2020, 33(4):e100206.
[11]	DUMONTAUD M, KORCHIA T, KHOUANI J, et al. Sexual dysfunctions in schizophrenia:Beyond antipsychotics. A systematic review[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2020, 98:109804. DOI URL
[12]	陈周文, 张四美, 万凤. 利培酮对首发精神分裂症患者泌乳素的影响及相关影响因素分析[J]. 临床心身疾病杂志, 2017, 23(4):25-27.
[13]	LIANG Y, HUANG J, TIAN J B, et al. Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia[J]. Clin Interv Aging, 2016, 11:153-157.
[14]	LI J, RICE M S, HUANG T, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women[J]. Diabetologia, 2018, 61(12):2549-2560. DOI URL
[15]	ZHANG Y, WANG Q, REYNOLDS G P, et al. Metabolic effects of 7 antipsychotics on patients with schizophrenia:a short-term,randomized,open-label,multicenter,pharmacologic trial[J]. J Clin Psychiatry, 2020, 81(3):19m12785.

组别	例数	性别		年龄/岁	BMI/（kg/m²）
组别	例数	男性/[例（%）]	女性/[例（%）]	年龄/岁	BMI/（kg/m²）
高PRL组	53	10（18.87）	43（81.13）	45.06±10.34	26.72±1.89
正常PRL组	37	27（72.97）	10（27.03）	42.67±12.47	26.53±2.12
统计值		26.34		1.62	0.44
P值		<0.001		0.14	0.66
组别	PANSS评分/分	空腹血糖/（mmol/L）	TC/（mmol/L）	TG/（mmol/L）	利培酮/（ng/mL）
高PRL组	42.74±7.28	4.40±0.35	4.31±0.84	1.70±0.78	32.89±18.60
正常PRL组	58.55±6.16	5.80±1.31	4.39±0.99	2.00±0.92	33.12±19.20
统计值	10.88	-6.40	-0.449	-1.657	1.270
P值	<0.001	<0.001	0.655	0.102	0.173

组别	例数	性别		年龄/岁	BMI/（kg/m²）
组别	例数	男性/[例（%）]	女性/[例（%）]	年龄/岁	BMI/（kg/m²）
高PRL组	53	10（18.87）	43（81.13）	45.06±10.34	26.72±1.89
正常PRL组	37	27（72.97）	10（27.03）	42.67±12.47	26.53±2.12
统计值		26.34		1.62	0.44
P值		<0.001		0.14	0.66
组别	PANSS评分/分	空腹血糖/（mmol/L）	TC/（mmol/L）	TG/（mmol/L）	利培酮/（ng/mL）
高PRL组	42.74±7.28	4.40±0.35	4.31±0.84	1.70±0.78	32.89±18.60
正常PRL组	58.55±6.16	5.80±1.31	4.39±0.99	2.00±0.92	33.12±19.20
统计值	10.88	-6.40	-0.449	-1.657	1.270
P值	<0.001	<0.001	0.655	0.102	0.173

项目	β值	标准误	Wald值	OR值（95%CI）	P值
年龄	0.016	0.020	0.680	1.016（0.978~1.056）	0.410
性别	2.763	0.556	24.696	15.843（5.329~47.105）	<0.001
BMI	0.484	0.424	1.306	1.623（0.707~3.725）	0.253
PANSS评分	-0.764	0.299	6.510	0.466（0.259~0.838）	0.011
空腹血糖	-2.932	0.681	18.537	0.053（0.014~0.202）	<0.001
TC	-0.800	0.995	0.647	0.449（0.064~3.157）	0.647
TG	-0.431	0.257	2.807	0.650（0.392~1.076）	0.094
利培酮	-0.919	0.912	1.015	0.399（0.067~2.384）	0.314

项目	β值	标准误	Wald值	OR值（95%CI）	P值
年龄	0.016	0.020	0.680	1.016（0.978~1.056）	0.410
性别	2.763	0.556	24.696	15.843（5.329~47.105）	<0.001
BMI	0.484	0.424	1.306	1.623（0.707~3.725）	0.253
PANSS评分	-0.764	0.299	6.510	0.466（0.259~0.838）	0.011
空腹血糖	-2.932	0.681	18.537	0.053（0.014~0.202）	<0.001
TC	-0.800	0.995	0.647	0.449（0.064~3.157）	0.647
TG	-0.431	0.257	2.807	0.650（0.392~1.076）	0.094
利培酮	-0.919	0.912	1.015	0.399（0.067~2.384）	0.314